Literature DB >> 7075657

A pharmacokinetic study of mianserin.

K P Maguire, T R Norman, G D Burrows, B A Scoggins.   

Abstract

The kinetics of mianserin have been evaluated in eight healthy male volunteers following a single oral dose of 60 mg. Plasma and blood concentrations of mianserin were measured by gas chromatography-mass fragmentography. The peak blood concentration observed was 65 microgram/1 at 3 h following the dose. Mean kinetic parameters (and range) calculated from the blood concentrations were: (t1/2)abs 1.1 h (0.3-2.8), (t1/2) alpha 2.5 h (0.9-4.7), (t1/2) beta 21 h (14-33), (Vd) beta 27.5 l/kg (16.8-46.5) and Cloral 0.98 l/kg/h (0.47-1.75). Blood/plasma concentration ratios ranged from 0.50-0.74.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7075657     DOI: 10.1007/bf00542048

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Poisoning with maprotiline and mianserin.

Authors:  P Crome; B Newman
Journal:  Br Med J       Date:  1977-07-23

2.  Placebo-controlled double-blind trial of mianserin hydrochloride.

Authors:  A H Smith; G S Naylor; J P Moody
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

3.  Controlled clinical trial of a new antidepressant (Org. GB 94) of novel chemical formulation.

Authors:  D Wheatley
Journal:  Curr Ther Res Clin Exp       Date:  1975-12

4.  Workshop on the clinical pharmacology and efficacy of mianserin.

Authors:  A Coppen; H Kopera
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

5.  Simultaneous measurement of dothiepin and its major metabolites in plasma and whole blood by gas chromatography-mass fragmentography.

Authors:  K P Maguire; T R Norman; G D Burrows; B A Scoggins
Journal:  J Chromatogr       Date:  1981-03-13

6.  Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).

Authors:  T M Itil; N Polvan; W Hsu
Journal:  Curr Ther Res Clin Exp       Date:  1972-07

7.  Mass fragmentographic assay of nanogram amounts of the antidepressant drug mianserin hydrochloride (Org GB 94) in human plasma.

Authors:  J J de Ridder; P C Koppens; H J van Hal
Journal:  J Chromatogr       Date:  1977-05-01

8.  Mianserin hydrochloride: a novel antidepressant.

Authors:  A Coppen; R Gupta; S Montgomery; K Ghose; J Bailey; B Burns; J J de Ridder
Journal:  Br J Psychiatry       Date:  1976-10       Impact factor: 9.319

9.  Mianserin: a decade of scientific development.

Authors:  M Peet; H Behagel
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

10.  Mianserin in the treatment of depression in general practice.

Authors:  J E Murphy; J F Donald; A L Molla
Journal:  Practitioner       Date:  1976-07
View more
  5 in total

Review 1.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

2.  Absolute bioavailability of mianserin tablets and solution in healthy humans.

Authors:  C J Timmer; S Pourbaix; J P Desager; M Sclavons; C Harvengt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

Review 3.  Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents.

Authors:  A J Flint
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

4.  A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.

Authors:  R J Riley; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

Review 5.  Pharmacokinetic optimisation of therapy with newer antidepressants.

Authors:  P J Goodnick
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.